David Young is the founder of KisoJi Biotechnology. KisoJi Biotechnology has raised $41M in total funding. Latest round: Series B.
David S. Young is the CEO of KisoJi Biotechnology Inc., an early-stage biotechnology company focused on discovering and developing antibody therapeutics. He is described as a surgeon-scientist turned CEO by the University of Toronto’s Temerty Medicine.
Full founder directory · Investor directory · Company funding database · Fundraising library